Breaking News, Financial News

Financial Report: Patheon

Terminated supply pact impact results

Patheon
 
1Q Revenues: $153.9 million (-12%)

1Q Loss: $19.4 million (earnings were $3.5 million 1Q11)

Comments: Commercial manufacturing revenues were $122.8 million (-17%), impacted by a terminated $32.9 million manufacturing supply agreement. Pharmaceutical Development Services were $31.1 million (+15%), due to higher development activities from new contracts across most sites.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters